Amphix Bio, Inc

Website
57 E Delaware Pl Apt 2802
Chicago, IL 60611

Amphix Bio, Inc. is a Chicago-based biotechnology company focused on developing innovative regenerative therapeutics aimed at promoting healing following traumatic injuries and enhancing human healthspan. Utilizing a transformative therapeutic platform based on supramolecular chemistry, the company aims to restore functionality in neurological and musculoskeletal disorders through effective, cell-free treatments.

Founded on over two decades of research by Prof. Samuel Stupp at Northwestern University, Amphix Bio's platform has been validated by numerous peer-reviewed publications and patents. The company is advancing a diverse pipeline of candidates, including therapies for acute spinal cord injury, ischemic stroke, and degenerative disc disease, among others.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesIllinoisChicagoAmphix Bio, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.